HERPES ZOSTER E VACINAÇÃO CONTRA VARICELA NA FAIXA ETÁRIA PEDIÁTRICA: UMA REVISÃO NARRATIVA
DOI:
https://doi.org/10.56238/arev7n12-247Palavras-chave:
Herpes Zoster na Infância, Vacinação Contra Varicela, ComplicaçõesResumo
Herpes zoster (HZ) é uma doença causada pela reativação do vírus varicela-zoster, que afeta a pele e os nervos e provoca uma erupção cutânea dolorosa, podendo levar a complicações graves, como neuralgia pós-herpética e redução da acuidade visual. Sua incidência é elevada após os 50 anos de idade e em imunossuprimidos, e menos frequente na faixa etária pediátrica. Infecção pregressa pelo vírus varicela-zoster (varicela) e imunização contra varicela são aspectos importantes no desenvolvimento da doença em crianças. Atualmente, a imunização contra varicela é recomendada pela Organização Mundial de Saúde (OMS) nos programas de vacinação infantil de rotina. Estudos consistentes sobre herpes zoster na infância e sua relação com a vacinação contra varicela são limitados. Portanto, este artigo objetivou analisar a doença em menores de 18 anos, sua prevalência, particularidades e complicações e a relação entre herpes zoster na infância e a imunização contra varicela.
Downloads
Referências
Sundström K, Weibull CE, Söderberg-Löfdal K, Bergström T, Sparén P, Arnheim-Dahlström L. Incidence of herpes zoster and associated events including stroke—a population-based cohort study. BMC Infectious Diseases. 2015 Oct 31;15(1).
Shirane R, Tang H, Hayashi K, Okuno Y, Iso H, Asada H, et al. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study. Journal of Medical Virology. 2016 Jul 29;89(2):313–7.
Södergren E, Mårdberg K, Nishimwe M, Bhavsar A, Alen Marijam, Bergström T, et al. Incidence and Burden of Herpes Zoster in Sweden: A Regional Population-Based Register Study. Infectious Diseases and Therapy. 2024 Jan 1;13(1):121–40.
Michiel van Gent, Ouwendijk WJD, Campbell VL, Laing KJ, Georges, Koelle DM. Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia. Journal of Neuroinflammation [Internet]. 2023 Jun 12 [cited 2024 Aug 16];20(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259006/
Carrusca C, Machado R, Albuquerque C, Cunha F. Herpes zoster como primeira manifestação de infeção por vírus varicela-zoster numa criança saudável. Nascer e crescer [Internet]. 2016 Mar 16 [cited 2025 Aug 26];25(1):38–41. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/8828
Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITAL. The Lancet. 1974 Nov;304(7892):1288–90.
Kang DH, Kwak BO, Park AY, Kim HW. Clinical Manifestations of Herpes Zoster Associated with Complications in Children. Children. 2021 Sep 24;8(10):845
Leung J, Dooling K, Marin M, Anderson TC, Harpaz R. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch. The Journal of Infectious Diseases [Internet]. 2022 Oct 21;226(Supplement_4):S470–7.
Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, et al. The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination. Pediatric Infectious Disease Journal. 2009 Nov;28(11):954–9.
Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infectious Diseases [Internet]. 2015 Nov 6;15(1). Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-015-1262-8.
Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clinical Infectious Diseases [Internet]. 2016 May 8;63(2):221–6. Available from: https://academic.oup.com/cid/article/63/2/221/1745553
Tseng HF, Bruxvoort K, Ackerson B, Luo Y, Tanenbaum H, Tian Y, et al. The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence. The Journal of Infectious Diseases [Internet]. 2019 Dec 12 [cited 2020 Feb 1]; Available from: https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiz652/5674927
Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ, et al. Incidence of Herpes Zoster Among Children: 2003–2014. Pediatrics [Internet]. 2019 Jun 10;144(1):e20182917. Available from: https://pediatrics.aappublications.org/content/144/1/e20182917
Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, et al. Incidence and Clinical Characteristics of Herpes Zoster Among Children in the Varicella Vaccine Era, 2005–2009. The Journal of Infectious Diseases. 2013 Aug 6;208(11):1859–68.
Katakam B, Kiran G, Kumar U. A prospective study of herpes zoster in children. Indian Journal of Dermatology [Internet]. 2016;61(5):534. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029240/
Takayama N, Takayama M, Takita J. Herpes zoster in healthy children immunized with varicella vaccine. The Pediatric Infectious Disease Journal [Internet]. 2000 Feb 1;19(2):169–70. Available from: https://pubmed.ncbi.nlm.nih.gov/10694011/
Luana, Moreira MA, Paulo, Leite RD, Roberto F. Herpes zoster infantil: um estudo retrospectivo de 10 anos. Research Society and Development. 2022 Jul 2;11(9):e3211931705–5.
View of Recidiva de Herpes Zoster como sintoma inicial da infecção pelo HIV em criança/Herpes Zoster recurrence as an initial symptom of HIV infection on a child [Internet]. Brazilianjournals.com.br. 2025 [cited 2025 Aug 26]. Available from: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/16180/13244
Sinan ÖZÇELİK. Herpes Zoster in Children: A Retrospective Study of 55 Cases. Uludağ Üniversitesi Tıp Fakültesi Dergisi [Internet]. 2020 Apr 1 [cited 2025 Aug 26];46(1):59–63. Available from: https://dergipark.org.tr/tr/pub/uutfd/issue/54667/688146?utm_source=chatgpt.com
Pietrzak MK, Pokorska-Śpiewak M. Shingles in Children. The Pediatric Infectious Disease Journal [Internet]. 2024 May 29 [cited 2024 Nov 10];43(8):e275–7. Available from: https://journals.lww.com/pidj/fulltext/2024/08000/shingles_in_children.21.aspx
Hwang JH, Kim KH, Han SB, Kim HH, Kim JH, Lee SY, et al. A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children. Clinical and Experimental Vaccine Research. 2019;8(2):116.
Pereira T, Sousa L, Valle T. Herpes zoster em crianças saudáveis: o rosto inocente da controvérsia. Revista Portuguesa de Clínica Geral. 2015 Jan 1;31(1):34–7.
Min SW, Kim YS, Nahm FS, Yoo DH, Choi E, Lee PB, et al. The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster. Medicine. 2016 Aug;95(33):e4616.
(PDF) Herpes Zoster in Children: A Retrospective Evaluation of 128 Cases. ResearchGate [Internet]. 2023 [cited 2025 Aug 26]; Available from: https://www.researchgate.net/publication/374659825_Herpes_Zoster_in_Children_A_Retrospective_Evaluation_of_128_Cases
Sampaio S, Rivitti EA. Manual of clinical dermatology. 4th ed. 2018.
Luis Fernando Valladales‐Restrepo, Velasquez-Quimara S, Jorge Enrique Machado‐Alba. Pharmacological Treatment of Herpes Zoster and Factors Associated with Its Recurrence. Antibiotics [Internet]. 2023 Apr 14;12(4):757–7. Available from: https://ncbi.nlm.nih.gov/pmc/articles/PMC10135046/
Qian J, Banks E, Macartney K, Heywood AE, Lassere MN, Liu B. Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort. Mayo Clinic Proceedings. 2021 Nov;96(11):2843–53.
Yasuhisa Tatebe, Soichiro Ushio, Satoru Esumi, Sada H, Ochi M, Kosuke Tamefusa, et al. Low‐dose acyclovir for prophylaxis of varicella‐zoster virus reactivation after hematopoietic stem cell transplantation in children. Pediatric Blood & Cancer. 2022 Sep 24;69(12).
Feng M, Zhang J, Zhang G. Case report: Relapsed disseminated cutaneous herpes zoster successfully treated with brivudine. European Journal of Inflammation. 2023 Jun 1;21.
Shinichi Imafuku, Takeuchi S, Urabe K, Arakawa M, Sasaki R, Oka D, et al. An exploratory study of the efficacy and safety of amenamevir for the treatment of herpes zoster in patients receiving immunosuppressive drugs. The Journal of Dermatology. 2024 Jul 24;51(10):1279–89.
Povey M, Henry O, Riise Bergsaker MA, Chlibek R, Esposito S, Flodmark CE, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial. The Lancet Infectious Diseases. 2019 Mar;19(3):287–97.
Leung J, Dooling K, Marin M, Anderson TC, Harpaz R. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch. The Journal of Infectious Diseases [Internet]. 2022 Oct 21;226(Supplement_4):S470–7.
Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. New England Journal of Medicine. 2015 May 28;372(22):2087–96.
Mitra D, Mitra B, Chopra A, Talukdar K, Saraswat N, Das J. A clinico-epidemiological study of childhood herpes zoster. Indian Dermatology Online Journal. 2018;9(6):383.
Plachouri KM, Gkentzi D, Varvarigou A, Georgiou S, Dimitriou G. Herpes zoster onset 9 years after first varicella zoster vaccination in a 11 year old child - a case report. Current Pediatric Reviews. 2019 Mar 18;15.
Duarte Malveiro, Firme R, Deuchande S, Pinheiro A, Nuno Lynce. Herpes Zoster In A 3-Month-Old Infant. Nascer e Crescer [Internet]. 2015 Dec 1;24(4):179–82. Available from: https://www.researchgate.net/publication/317470344_Herpes_Zoster_In_A_3-Month-Old_Infant
Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients. Neurology [Internet]. 2016 Jul 5;87(1):94–102. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932239/
Quesada D, Morsky L, Aguìñiga-Navarrete P, Garrett M. Pediatric Herpes Zoster. Clinical Practice and Cases in Emergency Medicine. 2019 Dec 17;4(1):32–4.
Qi Q, Cavanagh MM, Le Saux S, Wagar LE, Mackey S, Hu J, et al. Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older Individuals. PLoS Pathogens [Internet]. 2016 Oct 20;12(10). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/
Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrobial Agents and Chemotherapy. 1995 Jul 1;39(7):1546–53.
Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrobial Agents and Chemotherapy. 1995 Jul 1;39(7):1546–53.
Balfour HH, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, et al. Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients. New England Journal of Medicine. 1983 Jun 16;308(24):1448–53.
